Valuation: Progyny, Inc.

Capitalization 1.82B 1.56B 1.43B 1.36B 2.5B 175B 2.55B 17.14B 6.64B 83.01B 6.84B 6.69B 289B P/E ratio 2026 *
17.9x
P/E ratio 2027 * 15.8x
Enterprise value 1.65B 1.42B 1.3B 1.23B 2.27B 159B 2.31B 15.55B 6.03B 75.35B 6.2B 6.07B 263B EV / Sales 2026 *
1.2x
EV / Sales 2027 * 0.97x
Free-Float
76.73%
Yield 2026 *
-
Yield 2027 * -
1 day+4.26%
1 week+7.43%
Current month+30.38%
1 month+29.96%
3 months+18.98%
6 months-6.29%
Current year-5.67%
1 week 22.24
Extreme 22.2401
24.38
1 month 17.37
Extreme 17.37
24.39
Current year 16.1
Extreme 16.1
28.75
1 year 16.1
Extreme 16.1
28.75
3 years 13.39
Extreme 13.39
44.95
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 31/12/2021
Director of Finance/CFO 60 14/09/2020
Chief Operating Officer 56 16/04/2025
Director TitleAgeSince
Chairman 66 31/12/2021
Director/Board Member 77 15/12/2016
Director/Board Member 58 31/12/2021
Change 5d. change 1-year change 3-years change Capi.($)
+4.30%+7.43%+12.67%-32.01% 1.82B
-0.87%+1.38%+23.38%-18.67% 358B
+0.31%+3.31%-2.34%-13.33% 85.28B
+0.12%-1.11%-11.21%+11.45% 75.46B
+0.15%+11.28%+23.39%-40.61% 36.63B
-0.21%+2.89%-5.78%-11.87% 28.77B
+0.15%-0.73%-43.50%-35.46% 9.64B
+3.18%-5.91%-0.58%+143.15% 3.25B
-1.30%+6.56%-5.28%+221.70% 1.83B
-3.07%-1.01%-20.32% - 300M
Average +0.29%+1.40%-2.96%+24.93% 60.07B
Weighted average by Cap. -0.40%+3.42%+12.65%-13.84%

Financials

2026 *2027 *
Net sales 1.38B 1.19B 1.09B 1.03B 1.9B 133B 1.93B 13B 5.04B 63B 5.19B 5.08B 220B 1.5B 1.29B 1.18B 1.12B 2.07B 145B 2.1B 14.15B 5.48B 68.55B 5.64B 5.52B 239B
Net income 109M 93.81M 85.84M 81.52M 150M 10.52B 153M 1.03B 398M 4.98B 410M 401M 17.35B 125M 107M 98.03M 93.1M 171M 12.01B 174M 1.17B 455M 5.68B 468M 458M 19.81B
Net Debt -168M -144M -132M -126M -231M -16.19B -235M -1.58B -613M -7.66B -631M -618M -26.71B -359M -308M -282M -268M -493M -34.58B -502M -3.38B -1.31B -16.36B -1.35B -1.32B -57.03B
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
18/05/26 24.26 $ +4.34% 1,180,068
15/05/26 23.25 $ +1.66% 945,115
14/05/26 22.87 $ -2.72% 1,211,922
13/05/26 23.51 $ +0.26% 1,546,145
12/05/26 23.45 $ +3.99% 2,373,183
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
23.25USD
Average target price
28.55USD
Spread / Average Target
+22.78%

Quarterly revenue - Rate of surprise